Journal
ARTHRITIS RESEARCH & THERAPY
Volume 12, Issue 5, Pages -Publisher
BMC
DOI: 10.1186/ar3150
Keywords
-
Categories
Ask authors/readers for more resources
A cross-regulation between type I IFN and TNF alpha has been proposed recently, where both cytokines are hypothesized to counteract each other. According to this model, different autoimmune diseases can be viewed as disequilibrium between both cytokines. As this model may have important clinical implications, the present review summarizes and discusses the currently available clinical evidence arguing for or against the proposed cross-regulation between TNF alpha and type I IFN. In addition, we review how this cross-regulation works at the cellular and molecular levels. Finally, we discuss the clinical relevance of this proposed cross-regulation for biological therapies such as type I IFN or anti-TNF alpha treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available